|
|||||
|
|
Combination of nicotinamide mononucleotide and troxerutin induces full protection against doxorubicin-induced cardiotoxicity by modulating mitochondrial biogenesis and inflammatory response |
|
| Authors: | Khosroshahi Ahmad Jamei Mokhtari Behnaz Badalzadeh Reza |
| Affiliation: | 1.Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ;2.Department of Pediatrics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ;3.Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ;4.Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ;5.Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ;6.Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ; |
| Abstract: | Molecular Biology Reports - Clinical application of doxorubicin (DOX) is restricted due to its cardiotoxicity, reinforcing the significance of exploring new strategies to counteract DOX-induced... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |